ZMA

Natural health product licensed in Canada

Other names: ZINC MONOMETHIONINE ASPARTATE - ZMA
Licence holder: Canadian Premier Supplements Inc.
NPN or DIN-HM: 80109101
Status: Active licence
Licence date: 6 April 2021
Revision date: 28 April 2025
Form: Capsule
Route of administration: Orale
Application type: Officinale

If this product were sold in France

Dose déclarée au-delà d'une limite
Zinc: up to 30 mg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
Dose déclarée au-delà d'une limite
Magnésium: up to 450 mg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 300 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
À vérifier
Zinc: up to 30 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSA for adults (25 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
À vérifier
Magnésium: up to 450 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSA for adults (250 mg a day). Pour ce nutriment, le repère de l'EFSA ne porte que sur les apports ajoutés (compléments, aliments enrichis), pas sur ce qu'apporte l'alimentation courante.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and source	Per dosage unit, according to the source	Maximum per day, adult
Zinc Source : Aspartate de zinc	10 mg	30,000 µg
Zinc Source : Monométhionine de Zinc	10 mg	30,000 µg
Magnésium Source : Aspartate de magnésium	150 mg	450,000 µg

Non-medicinal ingredients

Hypromellose

Recommended doses in Canada

Population	Age	Quantity per serving	Frequency
Adultes	minimum: 19 years	1 Capsule	3 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps (to) maintain/support immune function/system. Helps in energy metabolism and tissue formation. Helps in the development and maintenance of bones and teeth. Helps to form red blood cells. Helps to maintain heart muscle function. Helps to maintain normal electrolyte balance. Helps to maintain the body's ability to metabolize nutrients. Maintains healthy hair, skin and nails.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.